Primary |
Drug Use For Unknown Indication |
20.5% |
Pain |
17.9% |
Analgesic Therapy |
10.3% |
Bone Pain |
10.3% |
Pain In Extremity |
10.3% |
Chemotherapy |
7.7% |
Abdominal Pain Upper |
5.1% |
Glaucoma |
5.1% |
Knee Arthroplasty |
2.6% |
Multiple Myeloma |
2.6% |
Phlebitis |
2.6% |
Prostate Cancer |
2.6% |
Sciatica |
2.6% |
|
Fall |
11.1% |
Hepatocellular Injury |
11.1% |
Metabolic Acidosis |
11.1% |
Overdose |
11.1% |
Renal Failure |
11.1% |
Somnolence |
11.1% |
Thrombocytopenia |
11.1% |
Urinary Retention |
11.1% |
Vomiting |
11.1% |
|
Secondary |
Drug Use For Unknown Indication |
34.7% |
Product Used For Unknown Indication |
27.7% |
Pain |
13.1% |
Cancer Pain |
3.4% |
Rheumatoid Arthritis |
2.1% |
Prostate Cancer |
2.0% |
Hypertension |
1.8% |
Bronchial Disorder |
1.7% |
Back Pain |
1.5% |
Insomnia |
1.5% |
Anxiety |
1.3% |
Depression |
1.3% |
Oral Neoplasm |
1.3% |
Abdominal Pain |
1.2% |
Bone Pain |
1.1% |
Multiple Myeloma |
1.1% |
Sciatica |
1.1% |
Hypercholesterolaemia |
0.8% |
Muscle Spasms |
0.8% |
Osteoporosis |
0.8% |
|
Renal Failure Acute |
11.8% |
Vomiting |
8.4% |
Urinary Retention |
7.6% |
Confusional State |
6.7% |
Road Traffic Accident |
6.7% |
Hepatocellular Injury |
5.9% |
Somnolence |
5.9% |
Cholestasis |
5.0% |
Pyrexia |
5.0% |
Respiratory Distress |
5.0% |
Toxic Skin Eruption |
5.0% |
Fall |
3.4% |
Sepsis |
3.4% |
Syndactyly |
3.4% |
Toxicity To Various Agents |
3.4% |
Transaminases Increased |
3.4% |
Drug Dependence |
2.5% |
Miosis |
2.5% |
Ovarian Cancer |
2.5% |
Pierre Robin Syndrome |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
22.5% |
Drug Use For Unknown Indication |
18.3% |
Pain |
17.4% |
Prophylaxis |
3.8% |
Multiple Myeloma |
3.4% |
Gastric Cancer |
3.0% |
Hypertension |
2.9% |
Hiv Infection |
2.8% |
Back Pain |
2.7% |
Non-small Cell Lung Cancer |
2.4% |
Osteoporosis |
2.4% |
Depression |
2.2% |
Thrombosis Prophylaxis |
2.2% |
Anxiety |
2.2% |
Constipation |
2.1% |
Ankylosing Spondylitis |
2.1% |
Plasma Cell Myeloma |
2.0% |
Rheumatoid Arthritis |
1.9% |
Unevaluable Event |
1.9% |
Bone Pain |
1.8% |
|
Vomiting |
13.3% |
Pyrexia |
8.0% |
Thrombocytopenia |
7.6% |
Somnolence |
6.8% |
Renal Failure Acute |
6.5% |
Weight Decreased |
6.5% |
Neutropenia |
4.9% |
Pulmonary Embolism |
4.9% |
Cytolytic Hepatitis |
4.2% |
Tachycardia |
4.2% |
Toxic Skin Eruption |
4.2% |
General Physical Health Deterioration |
3.8% |
Sepsis |
3.8% |
Pancytopenia |
3.4% |
Malaise |
3.0% |
Oedema |
3.0% |
Pulmonary Hypertension |
3.0% |
Renal Failure |
3.0% |
Tooth Extraction |
3.0% |
Rhabdomyolysis |
2.7% |
|
Interacting |
Product Used For Unknown Indication |
40.7% |
Drug Use For Unknown Indication |
25.9% |
Amputation Stump Pain |
11.1% |
Neuralgia |
7.4% |
Pain |
7.4% |
Ankylosing Spondylitis |
3.7% |
Confusional State |
3.7% |
|
Respiratory Depression |
28.6% |
Death |
14.3% |
Drug Interaction |
14.3% |
Partial Seizures |
14.3% |
Respiratory Distress |
14.3% |
Suicide Attempt |
14.3% |
|